SC
PODD icon

Stance Capital’s Insulet PODD Stock Holding History

Stance Capital’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2K Buy
+100
New +$16.7K ﹤0.01% 243

Other funds holding PODD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Stance Capital's PODD Position: Q2 2026 in Review

Stance Capital opened a new position in Insulet (PODD) in Q2 2026: 100 shares worth $15.2K. The stake represents ﹤0.01% of the portfolio and ranks #243 among its holdings.

722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Stance Capital held 100 shares of Insulet worth $15.2K as of Q2 2026.
  • Insulet was a new Stance Capital position in Q2 2026.
  • Insulet made up ﹤0.01% of Stance Capital's portfolio in Q2 2026, its #243 holding.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.